These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10159509)

  • 1. Are there options for donor-derived i.m. anti-D IgG preparations other than to prevent Rh(D) sensitization? The intravenous route.
    Rewald E
    Transfus Sci; 1995 Dec; 16(4):383-9. PubMed ID: 10159509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoprophylactic anti-Rho(D) treatment after mismatched transfusions.
    Ennker J; Maas DH; Schneider J
    Eur J Obstet Gynecol Reprod Biol; 1979 Apr; 9(2):117-24. PubMed ID: 233744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological testing during pregnancy in women given routine antenatal anti-D Ig prophylaxis.
    de Silva PM; Knight RC
    Transfus Med; 1997 Dec; 7(4):323-4. PubMed ID: 9510934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
    Huchet J; Brossard Y
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
    [No Abstract]   [Full Text] [Related]  

  • 5. A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion.
    Zeiler T; Wittmann G; Zingsem J; Weisbach V; Zimmermann R; Eckstein R
    Vox Sang; 1994; 66(3):243. PubMed ID: 8036796
    [No Abstract]   [Full Text] [Related]  

  • 6. A pharmacokinetic/pharmacodynamic model for the action of anti-D immunoglobulin in effecting circulatory clearance of Rh D+ red cells.
    Chapman GE
    Transfus Med; 1996 Sep; 6(3):227-33. PubMed ID: 8885152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
    Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
    Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)].
    Börner P; Deicher H; Bähr I; Chelius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
    Dtsch Med Wochenschr; 1977 May; 102(20):745-51. PubMed ID: 405190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative estimation by ELISA of IgG anti-D (RH1) antibodies in immunoglobulin preparations and in the sera of immunized donors].
    Lambin P; Debbia M; Béolet M; Brossard Y; Le Pennec PY; Rouger P
    Transfus Clin Biol; 2001 Feb; 8(1):17-22. PubMed ID: 11281060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Rh antibodies in haemolytic disease of the newborn.
    Hadley AG; Kumpel BM
    Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
    Högman C; Nilsson BA
    Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
    Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
    Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)].
    Börner P; Deicher H; Bähr I; Chalius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
    Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):485-92. PubMed ID: 820591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 17. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to Rh D--development and uses.
    Scott ML; Voak D
    Vox Sang; 2000; 78 Suppl 2():79-82. PubMed ID: 10938934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
    Alie-Daran SJ; Dugoujon JM; Fournie A
    Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
    [No Abstract]   [Full Text] [Related]  

  • 20. Why women are not receiving anti-Rh prophylaxis.
    Hussey RM
    Br Med J (Clin Res Ed); 1987 Jan; 294(6564):119. PubMed ID: 3032323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.